Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. - Wikidata - wikimedia - TriplyDB

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients.

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients.

http://www.wikidata.org/entity/Q34523261

about

Thyroid computed tomography imaging: pictorial review of variable pathologies.What is the Minimal Surgery for Papillary Thyroid Carcinoma?Genetic Testing in Differentiated Thyroid Carcinoma: Indications and Clinical Implications RAS mutations in thyroid cancer Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer.Integrated genomic characterization of papillary thyroid carcinoma Significance of the Extracapsular Spread of Metastatic Lymph Nodes in Papillary Thyroid Carcinoma 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer Conservative management of well-differentiated thyroid cancer Malignant thyroid bed mass after total thyroidectomy.Recurrence rate in regional lymph nodes in 737 patients with follicular or Hürthle cell neoplasms.Endoscopic tumor ablation for laryngotracheal intraluminal invasion secondary to advanced thyroid cancer.A Phase 1, Multi-Center, Open-Label, Dose-Escalation Study of 131I-CLR1404 in Subjects with Relapsed or Refractory Advanced Solid Malignancies.Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012 The thyroid cancer policy model: A mathematical simulation model of papillary thyroid carcinoma in The U.S. population.Current concepts and future directions in differentiated thyroid cancer.Aggressiveness of the tall cell variant of papillary thyroid carcinoma is independent of the tumor size and patient age.Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile The pros and cons of prophylactic central neck dissection in papillary thyroid carcinoma.S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI imaging.BRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltration.Autoantibody against WD repeat domain 1 is a novel serological biomarker for screening of thyroid neoplasia.MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro Multikinase inhibitors use in differentiated thyroid carcinoma.Prediction of extrathyroidal extension using ultrasonography and computed tomography.Thyroid cancer: burden of illness and management of disease Reproductive outcomes and nononcologic complications after radioactive iodine ablation for well-differentiated thyroid cancer.The expression of twist in differentiated thyroid carcinomas.Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.Preoperative imaging modalities to predict the risk of regional nodal recurrence in well-differentiated thyroid cancers Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma.A cross-specialty survey to assess the application of risk stratified surgery for differentiated thyroid cancer in the UK.Long-Term Follow-Up of the Therapeutic Outcomes for Papillary Thyroid Carcinoma With Distant Metastasis.Association between BRAF and RAS mutations, and RET rearrangements and the clinical features of papillary thyroid cancer Use of radioactive iodine for thyroid cancer.Geriatric thyroidology: An update.Role of Recombinant Human Thyrotropin (rhTSH) in the Treatment of Well-Differentiated Thyroid Cancer.Management of thyroid carcinoma-an experience in Bangladesh.Controversies and challenges in the management of well-differentiated thyroid cancer.

P2860

Q26748491-EA08B70A-E547-4FF7-89B3-F1420F07F403 Q26765080-8B0C799F-7CAC-4FFD-86E9-FD61E4DBEB10 Q26765085-694DB342-4041-4129-9C39-94505C4DA17A Q27026163-06FD1B97-069A-4902-8585-DD5B20613EB5 Q27851648-1EC40828-0D11-4D58-8C59-FC5D6C6E75EB Q28251986-FB11968C-D8D3-4DBF-9624-E05C8B0A2EE3 Q28266858-1117C9EB-23FE-4102-9C2C-A129F8492493 Q30367068-61F04750-855A-47B2-84D5-E40299719026 Q30387260-EAC4E7B4-691D-4358-B217-9368A06CBBF1 Q30449566-3F478514-E6DF-4F59-AE13-0C1DE9DF3889 Q30571649-83EF342C-712A-4A9B-A3BE-96A4F715F0DD Q33345373-F08EA5EB-1032-4580-894B-379835F1FA29 Q33427321-AFC96388-7BF6-4648-992E-B5E39D83245B Q33570297-54CCE34C-1197-4C3E-B7DC-263B98D6B137 Q33648181-EE9E2B6E-9BE2-44B7-96A8-61B194FC7539 Q33677589-E2106599-753F-4E5C-B40E-622809E07F55 Q33685745-3782C45B-5044-4566-A5CE-B4EBCFC0CBA9 Q33713817-70BA653C-0A5A-4D75-82DE-597D7E7CC8A8 Q33973108-7BBC46AA-21BA-4D45-B28E-9381BBAB7275 Q34027466-83C1D704-158E-44E6-A70C-9278FE855026 Q34103836-2853C04B-6BD9-45A0-ADC4-E5A79A1C299A Q34502078-EAE482BC-9601-4672-A505-B685A5359873 Q34615021-3A5EF709-F4D9-4638-96AC-1C40D7BB1EB3 Q34660901-28A20D40-C0D8-411A-A23A-B68F24C15CE1 Q34698065-C199FD20-D5C6-412B-91FA-97E83744408D Q34821078-CEE0E5E0-2FBF-4730-BF05-AB13D07E5D42 Q34918474-94C141C5-C7B4-45AE-BFD6-F5C0171DEA45 Q35121406-2186A2F9-8BDA-4C22-9FD1-4583D9BA8220 Q35163702-F764ED2E-0321-40F4-8D49-6E448BC28A5C Q35440774-0ABC55E5-4C01-4F91-A552-8341D73D4C59 Q35441834-0F62F0F3-381A-4593-95ED-237E31DD4F73 Q35558293-4865ED82-1B35-41F2-BC0B-B0C24B8AFB47 Q35760244-AE97EBA7-AECA-41F9-9080-9C841BA232FF Q35857918-07992E0F-06AE-4DA0-9A11-78964C54A913 Q35908104-2922FC58-5BC7-4654-8147-71E2F1389D48 Q35961413-AF281763-D704-42A9-8057-06B635CBDAB8 Q36107776-D188CCC5-0955-43E6-BD2F-8D34EB95F3DC Q36240455-AEC8DFFE-E58D-4840-82D6-727E403817AF Q36260094-39C36FAE-FA49-4297-8A58-6C43D3CEF040 Q36262288-070CB47E-93C8-4654-82E6-5F889BB2A83B

P2860

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients.

http://www.wikidata.org/entity/Q34523261

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Papillary thyroid carcinoma ma ...... onsecutively treated patients.

@ast

Papillary thyroid carcinoma ma ...... onsecutively treated patients.

@en

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades

@nl

type

label

Papillary thyroid carcinoma ma ...... onsecutively treated patients.

@ast

Papillary thyroid carcinoma ma ...... onsecutively treated patients.

@en

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades

@nl

prefLabel

Papillary thyroid carcinoma ma ...... onsecutively treated patients.

@ast

Papillary thyroid carcinoma ma ...... onsecutively treated patients.

@en

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades

@nl

P1433

Q34523261-0D7DCF49-0C3E-410D-9D2B-2B8F9D79A6FC

P1476

Q34523261-BE8B1804-1080-4CC4-9299-239B6CADE3A0

P2093

Q34523261-0E3CA7DC-E786-40E6-94F1-E5EFC76061E8

Q34523261-5551CE70-5BFD-459F-8557-41AFAEAEDF40

Q34523261-7F5144B5-D506-49C9-AFE1-1BED39AE14A5

Q34523261-8D4B7C7A-31E6-42C5-8C32-0D61D9453DA1

Q34523261-92444426-C7FD-48BF-8177-17B797033BA8

Q34523261-9DCA8B02-B233-428F-BD61-D068F38A7D5E

Q34523261-B8CDF1DE-1061-4845-8DF0-7A6B40175B35

Q34523261-BDC6EAAD-A58B-4664-8A6E-823E35BC8666

Q34523261-BECF2415-EA67-4A1A-847E-658D231C6B73

Q34523261-DEC45800-133F-413F-B1BB-76691F89710B

P2888

Q34523261-B39A9A93-A4D5-4735-9566-E15638B67E5E

P304

Q34523261-D7F44563-3B5D-4186-A0E1-0A1FCD1C0DCC

P31

Q34523261-CCD6E877-10AF-4DF9-9861-B77A91C986EF

P356

Q34523261-2718B423-4342-4F03-8430-EE142D462008

P433

Q34523261-3A309702-660A-45CA-88CB-A3BCB1093038

P478

Q34523261-27D8F4B5-A1FC-407F-8D06-8F898531EE28

P577

Q34523261-DE158E69-AA64-4904-A449-F8041A0AA4C4

P6179

Q34523261-67B16551-CC1B-4D90-AD49-63F9126C18BB

P698

Q34523261-E505C2F6-5B57-432D-B610-B41FEC3EBACB

P921

Q34523261-3134E956-C4F7-4791-ACAA-8B47BA0F5664

P356

S00268-002-6612-1

P1433

World Journal of Surgery

P1476

Papillary thyroid carcinoma ma ...... onsecutively treated patients.

@en

P2093

Ann L Oberg

http://www.w3.org/2001/XMLSchema#string

Brian P Mullan

http://www.w3.org/2001/XMLSchema#string

Bryan McIver

http://www.w3.org/2001/XMLSchema#string

Catherine E Dvorak

http://www.w3.org/2001/XMLSchema#string

Claudia C Powell

http://www.w3.org/2001/XMLSchema#string

Clive S Grant

http://www.w3.org/2001/XMLSchema#string

Colum A Gorman

http://www.w3.org/2001/XMLSchema#string

Eric J Bergstralh

http://www.w3.org/2001/XMLSchema#string

Geoffrey B Thompson

http://www.w3.org/2001/XMLSchema#string

Ian D Hay

http://www.w3.org/2001/XMLSchema#string

P2888

s00268-002-6612-1

P304

879-885

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00268-002-6612-1

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1000896133

http://www.w3.org/2001/XMLSchema#string

P698

12016468

http://www.w3.org/2001/XMLSchema#string

P921